As shown in Figure 4C, among non-MAFLD patients, patients with elevated IL-6 levels appeared to have a higher proportion of severe COVID-19 than those with normal IL-6 levels but the effect was not statistically significant (19.57% vs. 13.33%, p = 0.360). This evidence concerns the gene IL6 and COVID-19.